Molecular Mechanisms of LRRK1 Regulation of Bone Homeostasis
LRRK1调节骨稳态的分子机制
基本信息
- 批准号:10544742
- 负责人:
- 金额:$ 32.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-01-01 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:AcidsActinsAlbers-Schonberg diseaseAnimal ModelAntibodiesAppearanceBindingBiologicalBiological AssayBone MatrixBone ResorptionBone necrosisBrainCRISPR/Cas technologyChloride ChannelsComplexConsensus SequenceCoupledCytoplasmCytoskeletonDataDevelopmentDiffusionDockingDrug TargetingEnzymesExhibitsExocytosisF-ActinFemoral FracturesForteoFunctional disorderFutureGenderGene ModifiedGene MutationGeneticGoalsGrantHomeostasisIdeal 1ImpairmentIn VitroIntegral Membrane ProteinJawKinesinKnock-outKnockout MiceLAMP-2LeadLeucine-Rich RepeatLysosomesMeasuresMediatingMolecularMonitorMotorMovementMusMutant Strains MiceMutationOsteoclastsOsteogenesisOsteoporosisOvariectomyPatientsPeptidesPeripheralPharmaceutical PreparationsPharmacotherapyPhenotypePhosphorylationPhosphorylation SitePhosphotransferasesPlayPostmenopauseProcessProtein-Serine-Threonine KinasesProteinsProteomicsProtonsPublic HealthRegulationResistanceRiskRoleSerineSerine/Threonine PhosphorylationSignal TransductionTNFSF11 geneTherapeuticThreonineTissuesTubular formationVariantWild Type MouseWomanWorkbisphosphonatebonebone fracture repairbone turnovercathepsin Kexperimental studyextracellularimprovedin vivoinhibitorknockout genelive cell imagingmimeticsmutantnovelosteoporosis with pathological fractureoverexpressionprotein complexresponsesmall molecule inhibitorspine bone structuretherapeutic developmentvacuolar H+-ATPase
项目摘要
Project Summary/Abstract
Leucine rich repeat kinase 1 (LRRK1), a novel serine/threonine kinase, is expressed in bones, brain and other tissues.
We recently demonstrated that Lrrk1 gene knockout (KO) mice as well as a patient with a Lrrk1 gene mutation are
severely osteopetrotic due to osteoclast dysfunction and reduced bone resorption in long and vertebra bones. More
importantly, Lrrk1 KO mice had lifelong bone accumulation and responded normally to the anabolic actions of
teriparatide treatment but were resistant to ovariectomy (OVX)-induced bone boss. These observations make LRRK1
an ideal target of a novel anti-resorption drugs for treatment of osteoporosis. In this grant, our focus is to perform in
vivo and in vitro studies to study the role of LRRK1-mediated phosphorylation of osteopetrosis specific transmembrane
protein 1 (OSTM1) in the regulation of chloride channel 7 (CLC7) complex stabilization, lysosomal peripheral
movement, lysosomal acid secretion and OC function. To this end, we hypothesize that LRRK1 phosphorylation of
OSTM1 at residues of threonine 328 and serine 329 regulates OC function and bone resorption by stabilization of
OSTM1/CLC7 complex and promotion of lysosomal peripheral movement and lysosomal acid secretion into lacuna
in vivo. Four-year studies proposed in this grant will deliver the role of LRRK1 phosphorylation of threonine and serine
residues of OSTM1 in regulation of bone resorption in vitro and in vivo. The results of this application will help our
understanding of molecular mechanisms of LRRK1 and OSTM1 actions in osteoclast and develop potential inhibitors
of LRRK1 for treatment of osteoporosis in future.
项目摘要/摘要
亮氨酸富含重复蛋白1(LRRK1)是一种新的丝氨酸/苏氨酸激酶,在骨骼、脑等组织中均有表达。
我们最近证明了Lrrk1基因敲除(KO)小鼠和一名Lrrk1基因突变的患者是
由于长骨和椎骨中破骨细胞功能障碍和骨吸收减少而导致的严重的骨质疏松。更多
重要的是,Lrrk1 KO小鼠终生有骨积累,并对合成代谢作用做出正常反应
但对卵巢切除(OVX)诱导的骨BOSS耐药。这些观察使LRRK1
治疗骨质疏松症的新型抗吸收药物的理想靶点。在这笔赠款中,我们的重点是在
LRRK1介导的骨化症特异性跨膜磷酸化作用的体内和体外研究
蛋白1(OSTM1)在调节氯离子通道7(CLC7)复合体稳定、溶酶体外周的作用
运动、溶酶体酸分泌和OC功能。为此,我们假设LRRK1的磷酸化
苏氨酸328和丝氨酸329残基上的OSTM1通过稳定骨吸收调节OC功能和骨吸收
OSTM1/CLC7复合体促进溶酶体周向运动和溶酶体酸分泌进入腔隙
在活体内。这笔赠款提议的为期四年的研究将提供苏氨酸和丝氨酸的LRRK1磷酸化作用。
OSTM1在体内外调节骨吸收中的残留物。这个应用程序的结果将帮助我们的
了解LRRK1和OSTM1在破骨细胞中作用的分子机制及开发潜在的抑制剂
LRRK1用于治疗骨质疏松症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Weirong Xing其他文献
Weirong Xing的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Weirong Xing', 18)}}的其他基金
Molecular Mechanisms of LRRK1 Regulation of Bone Homeostasis
LRRK1调节骨稳态的分子机制
- 批准号:
10363250 - 财政年份:2022
- 资助金额:
$ 32.23万 - 项目类别:
Mechanisms of Lrrk1 Regulation of Osteoclast Function
Lrrk1 调节破骨细胞功能的机制
- 批准号:
8769087 - 财政年份:2014
- 资助金额:
$ 32.23万 - 项目类别:
Regulation of Bone Formation by Ephrin B1 Signaling Pathways
Ephrin B1 信号通路对骨形成的调节
- 批准号:
8051630 - 财政年份:2010
- 资助金额:
$ 32.23万 - 项目类别:
Regulation of Bone Formation by Ephrin B1 Signaling Pathways
Ephrin B1 信号通路对骨形成的调节
- 批准号:
7896362 - 财政年份:2010
- 资助金额:
$ 32.23万 - 项目类别:
相似海外基金
A novel motility system driven by two classes of bacterial actins MreB
由两类细菌肌动蛋白 MreB 驱动的新型运动系统
- 批准号:
22KJ2613 - 财政年份:2023
- 资助金额:
$ 32.23万 - 项目类别:
Grant-in-Aid for JSPS Fellows
The structural basis of plasmid segregation by bacterial actins
细菌肌动蛋白分离质粒的结构基础
- 批准号:
342887 - 财政年份:2016
- 资助金额:
$ 32.23万 - 项目类别:
Operating Grants
The structural basis for plasmid segregation by bacterial actins
细菌肌动蛋白分离质粒的结构基础
- 批准号:
278338 - 财政年份:2013
- 资助金额:
$ 32.23万 - 项目类别:
Operating Grants
Cytoplasmic Actins in Maintenance of Muscle Mitochondria
细胞质肌动蛋白在维持肌肉线粒体中的作用
- 批准号:
8505938 - 财政年份:2012
- 资助金额:
$ 32.23万 - 项目类别:
Differential Expression of the Diverse Plant Actins
多种植物肌动蛋白的差异表达
- 批准号:
7931495 - 财政年份:2009
- 资助金额:
$ 32.23万 - 项目类别:
Studies on how actins and microtubules are coordinated and its relevancy.
研究肌动蛋白和微管如何协调及其相关性。
- 批准号:
19390048 - 财政年份:2007
- 资助金额:
$ 32.23万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Interaction of myosin with monomeric actins
肌球蛋白与单体肌动蛋白的相互作用
- 批准号:
5311554 - 财政年份:2001
- 资助金额:
$ 32.23万 - 项目类别:
Priority Programmes
STRUCTURE/INTERACTIONS OF ACTINS AND ACTIN-BINDING PROTEIN
肌动蛋白和肌动蛋白结合蛋白的结构/相互作用
- 批准号:
6316669 - 财政年份:2000
- 资助金额:
$ 32.23万 - 项目类别: